Page last updated: 2024-11-03

prazosin and Retinal Degeneration

prazosin has been researched along with Retinal Degeneration in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramirez, CJ1
Minch, JD1
Gay, JM1
Lahmers, SM1
Guerra, DJ1
Haldorson, GJ1
Schneider, T1
Mealey, KL1

Other Studies

1 other study available for prazosin and Retinal Degeneration

ArticleYear
Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats.
    Pharmacogenetics and genomics, 2011, Volume: 21, Issue:2

    Topics: Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Boron Compounds; Cat

2011